Diagnostic Performance of Biochemical Parameters to Diagnose Endogenous Hyperinsulinemic Hypoglycaemia

INTRODUCTION: The gold standard for diagnosing endogenous hyperinsulinemic hypoglycaemia (EHH) is the fasting test. The respective diagnostic value of insulin, C-peptide, proinsulin and beta-hydroxybutyrate levels in relation to glucose levels at the end of the fasting test remains ill-defined. We, therefore, aimed to explore the relevance of these parameters based on a literature review and individual data provided by different authors. METHODS: Extensive literature research was conducted in the databases Embase and Medline to identify case reports and original studies that report data on the fasting test e.g. fasting duration, blood glucose and insulin levels at the end of the fast, as well as C-peptide, proinsulin and beta-hydroxybutyrate levels, where available. Histology after surgery was defined as the diagnostic gold standard for patients with positive fasting tests. RESULTS: Data on fasting tests of 522 individual patients and 36 individual controls were identified. Sensitivity and specificity of the fasting test were 75.7% [95%CI 71.8-79.2] and 94.4% [95%CI 81.9-98.5], respectively, in our cohort. Whereas blood glucose, insulin and C-peptide are measured and reported in most cases, proinsulin and beta-hydroxybutyrate were reported in only 51% and 50%, respectively. In relation to blood glucose levels, C-peptide concentrations reached higher diagnostic accuracy (AUC 0.97) than insulin (AUC 0.93). Meanwhile, proinsulin and beta-hydroxybutyrate had an even higher diagnostic accuracy (both AUC = 0.99). CONCLUSIONS: In our dataset, combined glucose and C-peptide showed a strong discriminatory performance for EHH. However, proinsulin and beta-hydroxybutyrate show the highest diagnostic accuracy for diagnosing EHH yet are not measured on a regular basis.

Authors

Institutions

Publication Details

Journal
European Journal of Endocrinology
Published
2026-11-18
DOI
https://doi.org/10.1093/ejendo/lvag218
Primary Topic
Pancreatic function and diabetes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Diagnostic Performance of Biochemical Parameters to Diagnose Endogenous Hyperinsulinemic Hypoglycaemia

Emanuel Christ, Julie Celine Refardt, Damian Wild, Matthias Hepprich et al.
1 links
European Journal of Endocrinology
Pancreatic function and diabetes
article

Diagnostic Performance of Biochemical Parameters to Diagnose Endogenous Hyperinsulinemic Hypoglycaemia

Emanuel Christ, Julie Celine Refardt, Damian Wild, Matthias Hepprich, Adrian V Vella, Peter Wiesli, Jochen Seufert, Sandrine Andrea Urwyler, Martin Thomas Freitag, Katharina Laubner, Mehmet Sözen, Julia G. Fricke, Manuela Schildmeijer, Lea Menz, Christina Romberg
article en

Abstract

INTRODUCTION: The gold standard for diagnosing endogenous hyperinsulinemic hypoglycaemia (EHH) is the fasting test. The respective diagnostic value of insulin, C-peptide, proinsulin and beta-hydroxybutyrate levels in relation to glucose levels at the end of the fasting test remains ill-defined. We, therefore, aimed to explore the relevance of these parameters based on a literature review and individual data provided by different authors. METHODS: Extensive literature research was conducted in the databases Embase and Medline to identify case reports and original studies that report data on the fasting test e.g. fasting duration, blood glucose and insulin levels at the end of the fast, as well as C-peptide, proinsulin and beta-hydroxybutyrate levels, where available. Histology after surgery was defined as the diagnostic gold standard for patients with positive fasting tests. RESULTS: Data on fasting tests of 522 individual patients and 36 individual controls were identified. Sensitivity and specificity of the fasting test were 75.7% [95%CI 71.8-79.2] and 94.4% [95%CI 81.9-98.5], respectively, in our cohort. Whereas blood glucose, insulin and C-peptide are measured and reported in most cases, proinsulin and beta-hydroxybutyrate were reported in only 51% and 50%, respectively. In relation to blood glucose levels, C-peptide concentrations reached higher diagnostic accuracy (AUC 0.97) than insulin (AUC 0.93). Meanwhile, proinsulin and beta-hydroxybutyrate had an even higher diagnostic accuracy (both AUC = 0.99). CONCLUSIONS: In our dataset, combined glucose and C-peptide showed a strong discriminatory performance for EHH. However, proinsulin and beta-hydroxybutyrate show the highest diagnostic accuracy for diagnosing EHH yet are not measured on a regular basis.

European Journal of Endocrinology
Mayo Clinic (US), University of Freiburg (DE), University of Basel (CH), University Medical Center Freiburg (DE), Erasmus MC (NL), University Hospital of Basel (CH), Mayo Clinic in Arizona (US), St. Claraspital (CH), Mayo Clinic in Florida (US), Kantonsspital Frauenfeld (CH), Kocaeli Üniversitesi (TR)
Good health and well-being
Pancreatic function and diabetes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon